OncoMatch/Clinical Trials/NCT03810651
Pencil Beam Scanning in Patients With Renal Tumors
Is NCT03810651 recruiting? Yes, currently enrolling (May 2026). This Early Phase 1 trial studies non-drug interventions for renal tumor.
This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.
Check if I qualifyExtracted eligibility criteria
Disease stage
Required: Stage III
Prior therapy
Cannot have received: radiation therapy
Cannot have received: chemotherapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify